P440: THE COMBINATION VENETOCLAX PLUS MCL1 OVERCOMES DRUG RESISTANCE IN ACUTE PROMYELOCYTIC LEUKEMIA

• D. A. Pereira-Martins,
• N. I. Noguera,
• T. Ottone,
• A. Diepstra,
• C. Ortiz,
• I. Weinhauser,
• G. Huls,
• J. J. Schuringa,
• E. M. Rego,
• E. Ammatuna

Affiliations

D. A. Pereira-Martins

1 Center for Cell Based Therapy, University of Sao Paulo, Ribeirao Preto, Brazil

N. I. Noguera

3 Department of Biomedicine and Prevention, University of Tor Vergata

T. Ottone

3 Department of Biomedicine and Prevention, University of Tor Vergata

A. Diepstra

5 Department of Pathology and Medical Biology, Cancer Research Centre Groningen, University Medical Center Groningen, Groningen, Netherlands

C. Ortiz

1 Center for Cell Based Therapy, University of Sao Paulo, Ribeirao Preto, Brazil

I. Weinhauser

1 Center for Cell Based Therapy, University of Sao Paulo, Ribeirao Preto, Brazil

G. Huls

2 Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Center Groningen, Groningen, Netherlands

J. J. Schuringa

2 Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Center Groningen, Groningen, Netherlands

E. M. Rego

1 Center for Cell Based Therapy, University of Sao Paulo, Ribeirao Preto, Brazil

E. Ammatuna

2 Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Center Groningen, Groningen, Netherlands